Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

An orthotopic bladder tumor model and the evaluation of intravesical saRNA treatment.

Kang MR, Yang G, Charisse K, Epstein-Barash H, Manoharan M, Li LC.

J Vis Exp. 2012 Jul 28;(65). pii: 4207. doi: 10.3791/4207.

2.

Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth.

Kang MR, Yang G, Place RF, Charisse K, Epstein-Barash H, Manoharan M, Li LC.

Cancer Res. 2012 Oct 1;72(19):5069-79. doi: 10.1158/0008-5472.CAN-12-1871. Epub 2012 Aug 6.

3.

Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.

Hadaschik BA, Adomat H, Fazli L, Fradet Y, Andersen RJ, Gleave ME, So AI.

Clin Cancer Res. 2008 Mar 1;14(5):1510-8. doi: 10.1158/1078-0432.CCR-07-4475.

4.

Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.

Hadaschik BA, Zhang K, So AI, Fazli L, Jia W, Bell JC, Gleave ME, Rennie PS.

Cancer Res. 2008 Jun 15;68(12):4506-10. doi: 10.1158/0008-5472.CAN-08-0238.

5.

In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.

Mugabe C, Matsui Y, So AI, Gleave ME, Baker JH, Minchinton AI, Manisali I, Liggins R, Brooks DE, Burt HM.

Clin Cancer Res. 2011 May 1;17(9):2788-98. doi: 10.1158/1078-0432.CCR-10-2981. Epub 2011 Feb 28.

6.

Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.

Pfost B, Seidl C, Autenrieth M, Saur D, Bruchertseifer F, Morgenstern A, Schwaiger M, Senekowitsch-Schmidtke R.

J Nucl Med. 2009 Oct;50(10):1700-8. doi: 10.2967/jnumed.109.065961.

7.

Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.

Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4511-8.

8.

Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft.

Inamoto T, Taniguchi K, Takahara K, Iwatsuki A, Takai T, Komura K, Yoshikawa Y, Uchimoto T, Saito K, Tanda N, Kouno J, Minami K, Uehara H, Hirano H, Nomi H, Kiyama S, Akao Y, Azuma H.

Oncotarget. 2015 Aug 28;6(25):21628-35.

9.

Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.

Hadaschik BA, Jackson J, Fazli L, Zoubeidi A, Burt HM, Gleave ME, So AI.

BJU Int. 2008 Aug 5;102(5):610-6. doi: 10.1111/j.1464-410X.2008.07669.x. Epub 2008 Apr 2.

10.

GFP image analysis in the mouse orthotopic bladder cancer model.

De Velasco MA, Tanaka M, Anai S, Tomioka A, Nishio K, Uemura H.

Oncol Rep. 2008 Sep;20(3):543-7.

PMID:
18695904
11.

An orthotopic bladder cancer model for gene delivery studies.

Kasman L, Voelkel-Johnson C.

J Vis Exp. 2013 Dec 1;(82):50181. doi: 10.3791/50181.

12.

Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis.

van der Horst G, van Asten JJ, Figdor A, van den Hoogen C, Cheung H, Bevers RF, Pelger RC, van der Pluijm G.

Eur Urol. 2011 Aug;60(2):337-43. doi: 10.1016/j.eururo.2011.05.005. Epub 2011 May 19.

PMID:
21616583
13.

An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies.

Watanabe T, Shinohara N, Sazawa A, Harabayashi T, Ogiso Y, Koyanagi T, Takiguchi M, Hashimoto A, Kuzumaki N, Yamashita M, Tanaka M, Grossman HB, Benedict WF.

Cancer Gene Ther. 2000 Dec;7(12):1575-80.

14.

Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2.

Takahashi T, Kushiro A, Nomoto K, Uchida K, Morotomi M, Yokokura T, Akaza H.

J Urol. 2001 Dec;166(6):2506-11.

PMID:
11696819
16.

A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.

Hadaschik BA, Black PC, Sea JC, Metwalli AR, Fazli L, Dinney CP, Gleave ME, So AI.

BJU Int. 2007 Dec;100(6):1377-84. Epub 2007 Sep 10.

17.

Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach.

Jäger W, Moskalev I, Janssen C, Hayashi T, Awrey S, Gust KM, So AI, Zhang K, Fazli L, Li E, Thüroff JW, Lange D, Black PC.

PLoS One. 2013;8(3):e59536. doi: 10.1371/journal.pone.0059536. Epub 2013 Mar 26.

18.

[Establishment and application of an orthotopic murine bladder cancer model].

Yang SM, Wen DG, Hou JQ, He J, Cen JN, Chen JH.

Ai Zheng. 2007 Apr;26(4):341-5. Chinese.

PMID:
17430648
19.

Fractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma.

Fazel J, Rötzer S, Seidl C, Feuerecker B, Autenrieth M, Weirich G, Bruchertseifer F, Morgenstern A, Senekowitsch-Schmidtke R.

Cancer Biol Ther. 2015;16(10):1526-34. doi: 10.1080/15384047.2015.1071735. Epub 2015 Jul 15.

20.

Intravesical growth of murine bladder tumors assessed by transrectal ultrasound.

Alexander AA, Liu JB, McCue P, Gomella LG, Ross RP, Lattime EC.

J Urol. 1993 Aug;150(2 Pt 1):525-8.

PMID:
8326595

Supplemental Content

Support Center